Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 114Lung Neoplasms 83Lymphoma 76Head and Neck Neoplasms 76Glioblastoma 75Squamous Cell Carcinoma of Head and Neck 71Breast Neoplasms 71Rectal Neoplasms 67Esophageal Neoplasms 63Prostatic Neoplasms 59Leukemia 57Central Nervous System Neoplasms 54Pancreatic Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Lymphoma, Non-Hodgkin 43Lymphoma, Large B-Cell, Diffuse 43Hodgkin Disease 42Lymphoma, Follicular 41Brain Neoplasms 40Leukemia, Lymphocytic, Chronic, B-Cell 39Esophageal Squamous Cell Carcinoma 39Colorectal Neoplasms 38Burkitt Lymphoma 37Gliosarcoma 36Lymphoma, Large-Cell, Immunoblastic 33Uterine Cervical Neoplasms 31Neoplasms 31Adenocarcinoma Of Esophagus 31Lymphoma, Mantle-Cell 30Lymphoma, B-Cell, Marginal Zone 29

Interventions

Hydroxychloroquine 4Standard of Care 2Sodium Chloride 2COH04S1 COVID-19 vaccine 2BNT162 Vaccine 2Azithromycin 2tocilizumab 1palbociclib 1ogalvibart 1monalizumab 1crexavibart 1cilgavimab and tixagevimab drug combination 1avdoralimab 1XAV-19 1Specimen Handling 1Radiotherapy 1Medical Marijuana 1Losartan 1Janus Kinase Inhibitors 1Ivermectin 1Interleukin-7 1HuMax-IL8 1Gelsolin 1CVnCoV COVID-19 vaccine 1COVID-19 Vaccines 12019-nCoV Vaccine mRNA-1273 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 11-palmityl-2-(4-carboxybutyl)-sn-glycero-3-phosphocholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × COVID-19 × Radiotherapy × Clear all
NCT04381988 2021-10-27

A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
4 enrolled 5 charts

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡